发明名称 |
METHODS USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE FOR TREATMENT OF CERTAIN LEUKEMIAS |
摘要 |
Methods of treating, preventing or managing leukemias are disclosed. The methods encompass the administration of an immunomodulatory compound of the invention known as Revlimid® or lenalidomide. The invention further relates to methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods of the invention are also disclosed. |
申请公布号 |
US2015265591(A1) |
申请公布日期 |
2015.09.24 |
申请号 |
US201514729934 |
申请日期 |
2015.06.03 |
申请人 |
Celgene Corporation |
发明人 |
Zeldis Jerome B. |
分类号 |
A61K31/454;A61K39/395;A61K45/06 |
主分类号 |
A61K31/454 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating leukemia in a human, which comprises administering to a human in need thereof a therapeutically effective amount of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione. |
地址 |
Summit NJ US |